Jimboomba Times

New Pfizer storage guidance could help rural Covid vaccine rollout

Sally Whyte
Updated September 21 2023 - 11:17pm, first published May 26 2021 - 10:30am
The Pfizer vaccine is expected to become the main vaccine to be used for people aged under 50 in Australia. Picture: Shutterstock
The Pfizer vaccine is expected to become the main vaccine to be used for people aged under 50 in Australia. Picture: Shutterstock

The Therapeutic Goods Administration has changed its storage conditions for the Pfizer vaccine, allowing the breakthrough vaccine to be stored longer at normal refrigeration temperatures, a move which could have a big impact on Australia's sluggish vaccine rollout.

Create a free account to read this article

or signup to continue reading

Sally Whyte

Sally Whyte

Federal Politics Reporter
I report on a range of issues in federal politics and the public service, with a real passion for how decisions made in Canberra affect the lives of Australians.
The Echidna Newsletter

Weekdays

The Echidna

Sharp. Close to the ground. Digging deep. Your weekday morning newsletter on national affairs, politics and more.